Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
0.005% latanoprost
DRUG
3 trials
Sponsors
Santen Inc.
, Otsuka Beijing Research Institute
Conditions
Ocular Hypertension
Open Angle Glaucoma or Ocular Hypertension
Open-Angle Glaucoma
Phase 1
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
Completed
NCT00868894
Santen Inc.
Ocular Hypertension, Open-Angle Glaucoma
Start: 2009-03-31
End: 2010-06-30
Updated: 2011-11-03
Phase 2
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
Completed
NCT00650338
Santen Inc.
Ocular Hypertension, Open-Angle Glaucoma
Start: 2008-03-31
End: 2008-10-31
Target: 165
Updated: 2011-11-03
Phase 3
OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
Completed
NCT05583474
Otsuka Beijing Research Institute
Open Angle Glaucoma or Ocular Hypertension
Start: 2022-09-27
End: 2024-12-26
Updated: 2025-03-27